Crux Wealth Advisors Novartis Ag Transaction History
Crux Wealth Advisors
- $252 Billion
- Q3 2025
A detailed history of Crux Wealth Advisors transactions in Novartis Ag stock. As of the latest transaction made, Crux Wealth Advisors holds 10,775 shares of NVS stock, worth $1.42 Million. This represents 0.55% of its overall portfolio holdings.
Number of Shares
10,775
Previous 10,146
6.2%
Holding current value
$1.42 Million
Previous $1.23 Billion
12.54%
% of portfolio
0.55%
Previous 0.52%
Shares
4 transactions
Others Institutions Holding NVS
# of Institutions
1,599Shares Held
137MCall Options Held
1.53MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...